Martin Kolb Selected Research

Pulmonary Fibrosis (Fibrosing Alveolitis)

1/2022	Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study.
1/2022	Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease.
1/2020	Current models of pulmonary fibrosis for future drug discovery efforts.
1/2018	Lysyl Oxidase-Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor-β1-induced Pulmonary Fibrosis.
1/2018	Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis.
1/2018	Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension.
1/2017	An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.
10/2016	Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.
4/2016	An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research.
1/2016	Stretch-induced Activation of Transforming Growth Factor-β1 in Pulmonary Fibrosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Kolb Research Topics

Disease

46	Fibrosis (Cirrhosis) 10/2022 - 06/2002
45	Idiopathic Pulmonary Fibrosis 07/2022 - 01/2008
26	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 08/2002
14	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2022 - 05/2009
14	Disease Progression 01/2022 - 04/2009
10	Infections 01/2021 - 10/2001
8	Inflammation (Inflammations) 01/2021 - 01/2003
5	Lung Diseases (Lung Disease) 10/2019 - 08/2010
4	Rheumatoid Arthritis 10/2022 - 01/2019
4	Pulmonary Hypertension 01/2022 - 05/2009
4	Emphysema 01/2019 - 11/2006
3	Neoplasms (Cancer) 08/2021 - 10/2002
3	Vascular Remodeling 01/2013 - 05/2009
2	Pneumonia (Pneumonitis) 01/2022 - 10/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 12/2012
2	Idiopathic Interstitial Pneumonias 01/2022 - 01/2020
2	Systemic Scleroderma (Systemic Sclerosis) 08/2021 - 01/2019
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2020 - 01/2019
2	Hypoxia (Hypoxemia) 01/2020 - 09/2017
2	Diarrhea 10/2019 - 05/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2017
2	Dyspnea (Shortness of Breath) 11/2018 - 01/2016
2	Hyperplasia 10/2016 - 09/2011
2	Peritoneal Fibrosis 03/2002 - 10/2001
1	Connective Tissue Diseases (Connective Tissue Disease) 10/2022
1	Sarcoidosis (Schaumann Disease) 03/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Cough 01/2022
1	Liver Diseases (Liver Disease) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	COVID-19 12/2020

Drug/Important Bio-Agent (IBA)

24	nintedanibIBA 01/2022 - 05/2014
11	CollagenIBA 01/2022 - 10/2001
10	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 11/2004
9	Proteins (Proteins, Gene)FDA Link 07/2022 - 08/2002
8	CytokinesIBA 03/2022 - 10/2001
8	Biomarkers (Surrogate Marker)IBA 08/2021 - 04/2009
8	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 08/2002
8	Transforming Growth Factor beta (TGF-beta)IBA 01/2008 - 10/2001
6	pirfenidoneIBA 11/2019 - 01/2016
6	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2009 - 10/2001
5	Pharmaceutical PreparationsIBA 08/2021 - 04/2005
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 01/2003
4	Biological ProductsIBA 11/2019 - 11/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 06/2002
3	Oxygen (Dioxygen)IBA 01/2021 - 01/2016
3	AnticoagulantsIBA 01/2021 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 11/2011
3	Phosphotransferases (Kinase)IBA 10/2019 - 04/2005
3	Hydroxyproline (4 Hydroxyproline)IBA 01/2018 - 10/2001
3	Proteoglycans (Proteoglycan)IBA 03/2014 - 03/2002
2	treprostinil FDA Link 01/2022 - 05/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2012
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2021 - 01/2017
2	Carbon MonoxideIBA 01/2020 - 10/2019
2	Sildenafil Citrate (Viagra)FDA Link 12/2019 - 11/2018
2	Tyrosine (L-Tyrosine)FDA Link 10/2019 - 01/2019
2	Therapeutic UsesIBA 01/2019 - 10/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2017
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2018 - 01/2018
2	AntacidsIBA 01/2017 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 07/2012
2	IntegrinsIBA 01/2016 - 12/2014
2	Crystallins (Crystallin)IBA 02/2015 - 03/2014
2	ChondroitinIBA 03/2014 - 02/2011
2	GlycosaminoglycansIBA 03/2014 - 02/2011
2	EnzymesIBA 03/2014 - 02/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2011 - 01/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2011 - 05/2009
2	Connective Tissue Growth FactorIBA 11/2004 - 10/2003
2	Tissue Inhibitor of Metalloproteinase-1IBA 11/2004 - 10/2003
1	Peptides (Polypeptides)IBA 10/2022
1	Rheumatoid FactorIBA 10/2022
1	Matrix Metalloproteinases (MMPs)IBA 07/2022
1	GelatinasesIBA 07/2022
1	ZincIBA 07/2022
1	EndopeptidasesIBA 07/2022
1	Monoclonal AntibodiesIBA 03/2022
1	Infliximab (Remicade)FDA Link 03/2022
1	Azathioprine (Imuran)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022
1	AerosolsIBA 01/2022
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	EicosanoidsIBA 01/2021
1	parecoxibIBA 01/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Cytochrome P-450 CYP3AIBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021

Therapy/Procedure

20	Therapeutics 03/2022 - 11/2007
3	Precision Medicine 01/2021 - 10/2015
3	Peritoneal Dialysis 02/2005 - 03/2002
1	Lung Transplantation 10/2022
1	Immunomodulation 03/2021
1	Noninvasive Ventilation 01/2021
1	Critical Care (Surgical Intensive Care) 12/2020